Blockade of LTP required a substantial preincubation period to be effective. Even at the highest concentration of emetine used to block LTP, no effect on any intracellularly recorded membrane properties was observed. In contrast, the protein synthesis inhibitor anisomycin was unable to block LTP. Puromycin aminonucleoside, a structural analogue of puromycin which is inactive in inhibiting protein synthesis, was ineffective in blocking LTP.
(LTP) in the hippocampus has attracted attention as a model of neuronal plasticity in the central nervous system. Although accumulating evidence associates protein synthesis with LTP, there is no direct proof that protein synthesis is actually required for the production of LTP. Therefore, we have examined the ability of some inhibitors of protein synthesis to modify LTP in the CA1 region of the rat hippocampal slice. Incubation for 30 min in the presence of emetine, cycloheximide, or puromycin decreased the frequency of occurrence of LTP in field CA1 elicited by repetitive stimulation of the Schaffer collaterals. This blockade was dose dependent and correlated with the ability of individual inhibitors to inhibit incorporation of [3H]valine into proteins. LTP blockade was irreversible for the irreversible inhibitor emetine and was reversible for the reversible inhibitor cycloheximide.
Blockade of LTP required a substantial preincubation period to be effective. Even at the highest concentration of emetine used to block LTP, no effect on any intracellularly recorded membrane properties was observed. In contrast, the protein synthesis inhibitor anisomycin was unable to block LTP. Puromycin aminonucleoside, a structural analogue of puromycin which is inactive in inhibiting protein synthesis, was ineffective in blocking LTP.
These experiments demonstrate that a variety of protein synthesis inhibitors are able to block the production of LTP in field CAl, suggesting the necessity for a set of newly synthesized or rapidly turned over proteins for hippocampal LTP.
In the hippocampus, brief, high frequency stimulation of afferents gives rise to a long-lasting increase in the amplitude of the evoked population action potential (population spike).
This phenomenon has been called long-term potentiation (LTP) and has been described for a number of neuronal inputs to the hippocampus (Bliss and L$mo, 1973; Schwartzkroin and Wester, 1975; Alger and Teyler, 1976) . The amplitude of the postsynaptic population spike is up to 10 times greater than the response prior to repetitive stimulation (Schwartzkroin and Wester, 1975) . LTP can last for weeks in the intact animal (Bliss and Garnder-Medwin, 1973; Douglas and Goddard, 1975) , and for the life of the hippocampal slice (up to 10 hr or longer) (Alger and Teyler, 1976; Andersen et al., 1977 1972), has led to speculation that LTP may provide a model for learning and memory.
Repetitive high frequency stimulation of the hippocampus produces numerous biochemical effects, including changes in protein phosphorylation patterns (Bar et al., 1982) , increases in specific protein fractions (Browning et al., 1979) , and increased secretion of newly synthesized proteins (Duffy et al., 1981) . However, it is not known whether synthesis of proteins is required for, or merely a by-product of, LTP.
Therefore, we investigated the ability of a variety of inhibitors of protein synthesis to block LTP in field CA1 of the hippocampal slice. In addition, we measured the inhibition of [3H]valine incorporation into proteins in slices by the various protein synthesis inhibitors.
We report here that the protein synthesis inhibitors emetine, cycloheximide, and puromycin are all effective in blocking LTP in field CA1 of the hippocampus. Concentrations effective in blocking LTP correlated well with concentrations needed to inhibit [3H]valine incorporation into proteins. In contrast, the protein synthesis inhibitor anisomycin was unable to block LTP at concentrations that were effective in inhibiting incorporation of [3H]valine. A preliminary version of this work has been reported previously (Stanton and Sarvey, 1983 was defined as the average of the amplitude from the peak early positivity to the peak negativity, and the amplitude from the peak negativity to the peak late positivity (Alger and Teyler, 1976) . Population spike amplitude has been shown to reflect the number and synchrony of neurons firing in the vicinity of the recording electrode (Andersen et al., 1971) , and to correlate with the slope of the excitatory postsynaptic potential as well as with spike latency (Bliss and Gardner-Medwin, 1973) . LTP was defined as a spike amplitude increase of greater than 2 SD from the mean of three control base lines (>35% increase) 30 min after repetitive stimulation, since in slices which showed potentiation at this time, potentiation lasted for hours (Fig. 1C) 
Results
Blockade of LTP in hippocampal slices by protein synthesis inhibitors. Figure 1 illustrates the population spike in field CA1 before and 30 min after a single train of repetitive stimuli to the Schaffer collaterals. An example of control LTP of approximately 200% increase in amplitude is shown in Figure lA . In Figure lB , emetine (1.5 PM) was added to another slice 30 min prior to repetitive stimulation and was present continuously until measurement of LTP 30 min after repetitive stimulation. During this time, the base line response remained stable. LTP was completely blocked, and the population spike was unaltered. Figure 1C illustrates the time course of typical changes in population spike amplitude after repetitive stimulation for a control potentiated slice and for a slice treated with emetime (1.5 FM). Although LTP was routinely assessed 30 min after repetitive stimulation, this time course demonstrates that the response can remain potentiated for at least 5 hr. Furthermore, emetine had no effect on the population spike over the 5-hr period.
Three protein synthesis inhibitors were effective in blocking production of LTP in CA1 in a dose-dependent manner. Slices were preincubated for 30 min with one of the protein synthesis inhibitors, emetine, cycloheximide, or puromycin. The Schaffer collaterals were then repetitively stimulated, and the slices were maintained in the drug solution for an additional 30 min; after this time, population spike amplitude was measured. The percentage of slices exhibiting LTP in control versus drug conditions is shown in Figure 2A . Note that, in control conditions, 57% of the slices exhibited LTP.
The intermediate and high concentrations of emetine and cycloheximide, and the high concentration of puromycin, were all able to significantly decrease the frequency of LTP observed in CA1 (x2, p < 0.05). In contrast, the low concentrations of all three inhibitors did not significantly decrease the frequency of LTP. There were no alterations in population spike waveform or amplitude produced by any of the three inhibitors over the course of the experiments, with the exception of the highest concentration of cycloheximide (35 gM), which occasionally produced a transient increase in spike amplitude, followed by at most a 20% depression. The effect of puromycin (100 PM) on the population spike was followed for longer time periods. Puromycin had no effect on population spike waveform or amplitude for periods up to 3 hr (N = 4), but multiple population spikes were occasionally observed after this time. of protein synthesis at concentrations that block LTP suggest that almost complete inhibition of protein synthesis is necessary to impair the production of LTP.
Blockade of LTP by emetine requires a preincubation period. In a variety of cellular systems, protein synthesis inhibitors are found to require several minutes to penetrate the cell, bind to ribosomes, and inhibit protein synthesis (Grollman, 1968) . If protein synthesis inhibition is the mechanism of LTP blockade, we would expect a preincubation period to be necessary for effective blockade. Conversely, if a faster-acting property of these inhibitors is the mechanism of LTP blockade, we would expect the presence of the inhibitor during and after the repetitive stimulation to be sufficient to block LTP. As shown in Figure 3 These results show that blockade of LTP by emetine is not simply a result of nonspecific membrane effects since, when emetine was present in the bath only from the time of repetitive stimulation, and for 30 min after, LTP was no longer blocked. Reversibility of protein synthesis inhibition and blockade of LTP. To establish further that these inhibitors block LTP by inhibiting protein synthesis, we determined whether differences in the reversibility of their inhibition of protein synthesis were matched by differences in reversibility of their blockade of LTP. Emetine is an irreversible inhibitor of protein synthesis, whereas cycloheximide is a reversible inhibitor of protein synthesis (Grollman, 1968) . Measurement of t3H]valine incorporation in slices verified this observation.
Slices were treated with the same incubation and wash paradigm, shown in Figure  4A . Inhibition by emetine of [3H]valine incorporation in slices was not reversed by a 2-hr wash, whereas inhibition by cycloheximide was reversible. Figure 4B illustrates that the differences in reversibility also apply to the blockade of LTP. As usual, preincubation for 30 min with either emetine (1.5 pM) or cycloheximide (3.5 PM) blocked the induction of LTP (x", p < 0.05). These same slices were then washed in drug-free buffer for 2 hr, after which a second repetitive stimulation was applied. Slices treated with the irreversible protein synthesis inhibitor emetine were still unable to potentiate (N = 4, x2, p < 0.05). However, slices treated with the reversible inhibitor cycloheximide were capable a structural analogue of puromycin that is relatively ineffective of exhibiting LTP after the wash (N = 3). These results further in inhibiting protein synthesis (Agranoff et al., 1966) . Experisupport a link between LTP blockade and inhibition of protein ments with PA are summarized in Figure 5 . Measurement of synthesis. In addition, the ability of these slices to support of LTP by protein synthesis inhibitors. Inhibition of catecholamine synthesis is a side effect of cycloheximide, puromycin, and anisomycin, which has been suggested as a possible mechanism of their behavioral effects (Flexner and Goodman, 1975) . Other studies have indicated that inhibition of tyrosine hydroxylase, the rate-limiting enzyme in catecholamine synthesis, is not responsible for the behavioral effects of protein synthesis inhibitors (Squire et al., 1974) . The possibility that inhibition of catecholamine synthesis by protein synthesis inhibitors might be responsible for blockade of LTP was evaluated by bath applying a-methyl-p-tyrosine (AMPT; 100 PM), an irreversible inhibitor of tyrosine hydroxylase. A 30-min preincubation with AMPT was unable to block LTP in CA1 (N = 8). Therefore, inhibition of catecholamine synthesis cannot be responsible for blockade of LTP in field CAL Intracellularly recorded membrane parameters are not affected by emetine. There have been suggestions that some protein synthesis inhibitors may exhibit nonspecific neuronal membrane depressant effects. Of the inhibitors we employed to block LTP, emetine seems to be lacking in such nonspecific membrane effects. As can be seen in Figure lB , emetine (1.5 PM) produced no effect on the shape or amplitude of the extracellular response. This would suggest that the only effect of emetine is blockade of LTP. To further ensure that the blockade of LTP was not due to a nonspecific effect on the neuronal membrane too subtle to be seen in the population spike, we recorded intracellularly in the presence of emetine (Table I) . We found that even the highest concentration of emetine (15 pM) applied for 1 hr produced no changes in resting membrane potential, input resistance, action potential amplitude or duration, EPSP amplitude, IPSP amplitude, threshold for either a synaptically or directly evoked action potential, accommodation to a depolarizing current step, or the CA'+-dependent K+ afterhyperpolarization (N = 5, paired t test). Figure 6 shows the extracellular population spike (Fig. 6A ), intracellular action potential (Fig. 6B) , and response to a depolarizing current step (Fig. 6C ) in a typical cell before, and 30 min after, emetine was added. These data make it very unlikely that some generalized alteration of membrane or channel properties leading to altered neuronal excitability is responsible for emetine's blockade of LTP.
Anisomycin is a protein synthesis inhibitor unable to block LTP. Reports in the literature have suggested that the pyrrolidine protein synthesis inhibitor anisomycin was unable to block LTP (Swanson et al., 1982) . Therefore, we evaluated the ability of anisomycin to modify LTP in field CAl. Anisomycin was added to the bath 30 min before repetitive stimulation and was present continuously until assessment of LTP 30 min after repetitive stimulation.
None of the concentrations employed (3.8 to 190 pM) was able to alter the frequency of occurrence of LTP in field CA1 as tested by x2 analysis. However, when the population spike amplitude 30 min after repetitive stimulation was compared by a paired t test with prestimulation amplitude in all slices, including those that failed to meet the criterion for LTP, an average increase in spike amplitude was not seen at any concentration of anisomycin tested. By this criterion, anisomycin blocked LTP. On those occasions when LTP did occur, the average amplitude of LTP in untreated slices was 311 f 89.1% (N = 16, percentage of prestimulated base line responses), while the amplitude of LTP in anisomycin-treated slices was 199 f 31.2% (N = 9), and the LTP amplitude in those treated with the other inhibitors was 196 f 24.1% (N = 6). Therefore, we conclude that emetine, cycloheximide, and puromycin may be able to decrease both occurrence and amplitude of LTP, whereas anisomycin appears only to decrease LTP amplitude and not prevent its occurrence. This suggests a qualitative difference between anisomycin's actions and those of the other protein synthesis inhibitors.
Measurement of anisomycin's inhibition of [3H]valine incorporation into TCA-precipitable proteins indicated that all concentrations of anisomycin employed inhibited more than 90% (N = 6).
Further experiments were performed to determine whether a greater time lag in the drug's effectiveness might be responsible for its failure to block LTP. Preincubation in anisomycin for up to 2 hr did not block LTP (N = 4) Whereas evidence has accumulated linking LTP with increased protein synthesis (Browning et al., 1979; Duffy et al., that functioning protein synthesis is required for LTP. However, we cannot say whether that role is in the activity-related 1981), it was not previously known whether synthesis of prosynthesis of a set of proteins not previously expressed, an teins is necessary for LTP. The data presented here suggest increase in the rate of synthesis of a set of proteins already Vol. 4, No. 12, Dec. 1984 the amnestic effects of these inhibitors (Barondes and Cohen, 1967; Barondes, 1970) .
Furthermore, the requirement of a preincubation period for blockade of LTP by emetine suggests that inhibition of protein synthesis needs to be effective at or fairly soon after the repetitive stimulation.
Further experiments to determine the precise time course of the blockade of LTP will be important in identifying the kinds of proteins, what post-translational processing may be possible, and their sites of synthesis and action in supporting LTP.
Although the primary effect of these compounds is inhibition of protein synthesis, neuronal side effects have been reported for some of these inhibitors. Cycloheximide and puromycin have been shown to have a direct local anesthetic effect, but at concentrations significantly higher than those used in our studies (Paggi and Toschi, 1971) . In our slice preparation, the low and intermediate concentrations of cycloheximide had no effect on population spike amplitude or waveform when present up to 2 hr. However, the highest dose of cycloheximide exhibited an ability to transiently increase and then depress population spike amplitude.
Puromycin injected intracerebrally in mice produces striking epileptiform abnormalities in hippocampal theta rhythm, but these effects occur 5 hr after injection (Cohen et al., 1966) . In our slice preparation, there is no effect of puromycin on population spike amplitude or waveform for up to 3 hr. However, in some slices followed for longer time periods, multiple evoked population spikes are sometimes observed. Given the delayed onset of these effects, we believe that they are not important in LTP blockade. One of the side effects exhibited by some of these protein synthesis inhibitors which has been proposed as a possible explanation for their neuronal effects on behavior is inhibition of catecholamine synthesis (Flexner and Goodman, 1975) .
However, preincubation with the irreversible tyrosine hydroxylase inhibitor AMPT indicated that inhibition of catecholamine synthesis will not block LTP in CAl.
The general consensus has been that anisomycin and emetine are relatively specific protein synthesis inhibitors lacking many of the side effects attributed to other inhibitors (Barondes, 1970; Flood et al., 1973; Dunn, 1976) . In fact, extracellular population spike amplitudes and waveforms show no significant changes with bath application of either emetine or anisomycin, at any of the concentrations tested, for several hours. Furthermore, CA1 pyramidal neurons appear to be completely unaffected by the highest concentration of emetine in a wide range of intracellularly recorded membrane parameters. The specificity of the blockade of LTP was demonstrated in two ways. First, even the highest concentration of emetine employed to block LTP does not alter the waveform of the extracellular field potential or any of the pre-and postsynaptic membrane properties we measured by intracellular recording. Second, the short-term example of activity-related plasticity we call STP cannot be blocked by inhibition of protein synthesis. Previous studies have shown that STP is not a necessary condition for production of LTP (Misgeld et al., 1979) . It has also recently been shown that specific blockade of postsynaptic population spike firing with tetrodotoxin, y-aminobutyric acid, or pentobarbital blocks production of LTP, without affecting the production of STP (Scharfman and Sarvey, 1983) . Our results further support a sharp differentiation between STP and LTP.
The ability of three protein synthesis inhibitors with differing mechanisms of action to block LTP, the close parallel in doseresponse relations for blockade and inhibition of [3H]valine incorporation, and the close parallels in time course and reversibility all support the conclusion that these inhibitors block LTP by inhibiting protein synthesis. However, these results conflict with the inability of anisomycin to prevent LTP, although our studies indicate that anisomycin may be able to reduce the amplitude of LTP when it does occur. Although we have ruled out a longer time lag in the drug's effectiveness, inactivation of the drug over time, or inhibition of valine uptake as possible explanations for this difference, other possible explanations remain to be tested. It is important to remember that our use of [3H]valine incorporation to measure inhibition of protein synthesis is an overall measure of such synthetic rates and may not reflect a relative resistance of a subclass of protein synthesis to anisomycin.
Indeed, Steward and Levy (1982) have visualized a subclass of ribosomes localized to the dendritic spines of hippocampal neurons. Studies of the pharmacology of these uniquely placed ribosomes may prove very fruitful, and anisomycin may prove to be a useful tool in determining what components of protein synthesis are important in the production of LTP. A large amount of data has accumulated correlating the appearance of newly synthesized proteins in the hippocampus with acquisition of a learned behavior (Hyden and Lange, 1970, 1983) . Also, it has been shown that the production of LTP in the hippocampus is associated with a preferential increase in the synthesis of proteins destined for secretion into the extracellular space (Duffy et al., 1981 
